Skip to main content
Clinical Trials/NCT02200185
NCT02200185
Completed
Not Applicable

Efficacy and Safety of Nebulized Morphine Given at Two Different Doses Compared to Intravenous Morphine in Post-traumatic Acute Pain: a Randomized Controlled Double Blind Study

University of Monastir1 site in 1 country300 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
IV titrated morphine
Conditions
Post-Traumatic Headache
Sponsor
University of Monastir
Enrollment
300
Locations
1
Primary Endpoint
Pain resolution
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The investigators test a different technique using morphine to improve pain relief in patient visiting the emergency department with acute trauma pain, for this we are comparing three different methods of morphine administration:

  • intravenous titrated morphine
  • low dose nebulized morphine and
  • high dose nebulized morphine

Detailed Description

Trauma patients are frequent in emergency department settings, and often require urgent care. taking care of this patients consists on taking care of their pain and then the specific treatment of their traumatic lesions. actually, the most used medicine and most efficient one in treating pain is morphine, it's mechanism of action is by acting on receptors located on neuronal cell membranes and inhibit neurotransmitter release. The most applied administration root of morphine is by intravenous (IV) titration or IV continuous perfusion, but until now, there is no clear recommendation concerning the superiority of this root over other administration techniques such as nebulization. In this study we aimed to investigate the efficiency, the feasibility and the tolerance of three morphine administration roots in patients with acute traumatic pain and to clarify the most adequate one to apply in emergency department settings.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
July 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nouira

Professor

University of Monastir

Eligibility Criteria

Inclusion Criteria

  • patients older than 8 years and less than 50 years
  • patients who consult emergency department for sever pain after an immediately trauma

Exclusion Criteria

  • Glasgow coma scale \<14
  • inability to cooperate
  • hypotension with systolic blood pressure\< 90mmhg
  • bradypnea\<12cpm
  • SAO2\<90%
  • polytrauma
  • nasal trauma
  • nasal obstruction
  • allergy to opioids

Arms & Interventions

IV titrated morphine

patient will receive 2 mg morphine each 5 min, associated to continuous nebulisation of saline serum (placebo). Morphine administration is stopped when VAS becomes under 50% and treatment failure is defined as VAS \> 50%, 30 minutes after the beginning of the protocol.

Intervention: IV titrated morphine

Low dose nebulised morphine

patient will receive 10 mg of morphine prepared with 4 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes. Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo

Intervention: Low dose nebulised morphine

High dose nebulised morphine

patient will receive 20 mg of morphine prepared with 3 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes. Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo.

Intervention: High dose nebulised morphine

Outcomes

Primary Outcomes

Pain resolution

Time Frame: 30 minutes

primary end point defined by the decrease in intensity pain objectified by a decline in visual analogy pain scale greater than or equal to 50% of its initial value

Secondary Outcomes

  • side effects(30 minutes)

Study Sites (1)

Loading locations...

Similar Trials